Janux Therapeutics Inc (JANX) — Financial Flexibility Index
Janux Therapeutics Inc (JANX) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of $-12.06 Million (operating CF $-12.34 Million minus capex $273.00K) represents 0% of total liabilities ($86.69 Million). Check JANX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Janux Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Janux Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see JANX cash flow conversion.
Annual Financial Flexibility Index for Janux Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Janux Therapeutics Inc. Explore Janux Therapeutics Inc (JANX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.60x | $-81.19 Million | $-82.23 Million | $50.70 Million | ▼ -42.7% |
| 2024 | -1.12x | $-43.45 Million | $-43.81 Million | $38.73 Million | ▲ +17.0% |
| 2023 | -1.35x | $-48.73 Million | $-50.58 Million | $36.06 Million | ▼ -60.3% |
| 2022 | -0.84x | $-36.48 Million | $-42.92 Million | $43.27 Million | ▲ +26.6% |
| 2021 | -1.15x | $-15.49 Million | $-16.98 Million | $13.50 Million | ▼ -1126.9% |
| 2020 | -0.09x | $-2.89 Million | $-4.37 Million | $30.86 Million | ▲ +65.6% |
| 2019 | -0.27x | $-2.35 Million | $-3.83 Million | $8.62 Million | — |